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A B S T R A C T
Background
Surgery is the preferred treatment for resectable oesophageal cancers, and canbe performed indifferentways. Transhiatal oesophagectomy
(oesophagectomy without thoracotomy, with a cervical anastomosis) is one way to resect oesophageal cancers. It can be performed
laparoscopically or by open method. With other organs, laparoscopic surgery has been shown to reduce complications and length of
hospital stay compared to open surgery. However, concerns remain about the safety of laparoscopic transhiatal oesophagectomy in
terms of post-operative complications and oncological clearance compared with open transhiatal oesophagectomy.
Objectives
To assess the benefits and harms of laparoscopic versus open oesophagectomy for people with oesophageal cancer undergoing transhiatal
oesophagectomy.
Search methods
We electronically searched the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library, MEDLINE,
EMBASE, Science Citation Index Expanded, and trials registers until August 2015. We also searched the references of included trials
to identify further trials.
Selection criteria
We considered randomised controlled trials and non-randomised studies comparing laparoscopic with open transhiatal oesophagectomy
in patients with resectable oesophageal cancer, regardless of language, blinding, or publication status for the review.
Data collection and analysis
Three review authors independently identified trials, assessed risk of bias and extracted data. We calculated the risk ratio (RR) or hazard
ratio (HR) with 95% confidence intervals (CI), using both fixed-effect and random-effects models, with RevMan 5, based on intention-
to-treat analyses.
1Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Main results
We found no randomised controlled trials on this topic. We included six non-randomised studies (five retrospective) that compared
laparoscopic versus open transhiatal oesophagectomy (334 patients: laparoscopic = 154 patients; open = 180 patients); five studies (326
patients: laparoscopic = 151 patients; open = 175 patients) provided information for one or more outcomes. Most studies included a
mixture of adenocarcinoma and squamous cell carcinoma and different stages of oesophageal cancer, without metastases. All the studies
were at unclear or high risk of bias; the overall quality of evidence was very low for all the outcomes.
The differences between laparoscopic and open transhiatal oesophagectomy were imprecise for short-term mortality (laparoscopic =
0/151 (adjusted proportion based on meta-analysis estimate: 0.5%) versus open = 2/175 (1.1%); RR 0.44; 95% CI 0.05 to 4.09;
participants = 326; studies = 5; I² = 0%); long-term mortality (HR 0.97; 95% CI 0.81 to 1.16; participants = 193; studies = 2; I² =
0%); anastomotic stenosis (laparoscopic = 4/36 (11.1%) versus open = 3/37 (8.1%); RR 1.37; 95% CI 0.33 to 5.70; participants = 73;
studies = 1); short-term recurrence (laparoscopic = 1/16 (6.3%) versus open = 0/4 (0%); RR 0.88; 95% CI 0.04 to 18.47; participants
= 20; studies = 1); long-term recurrence (HR 1.00; 95% CI 0.84 to 1.18; participants = 173; studies = 2); proportion of people who
required blood transfusion (laparoscopic = 0/36 (0%) versus open = 6/37 (16.2%); RR 0.08; 95% CI 0.00 to 1.35; participants = 73;
studies = 1); proportion of people with positive resection margins (laparoscopic = 15/102 (15.8%) versus open = 27/111 (24.3%);
RR 0.65; 95% CI 0.37 to 1.12; participants = 213; studies = 3; I² = 0%); and the number of lymph nodes harvested during surgery
(median difference between the groups varied from 12 less to 3 more lymph nodes in the laparoscopic compared to the open group;
participants = 326; studies = 5).
The proportion of patients with serious adverse events was lower in the laparoscopic group (10/99, (10.3%) compared to the open
group = 24/114 (21.1%); RR 0.49; 95% CI 0.24 to 0.99; participants = 213; studies = 3; I² = 0%); as it was for adverse events in the
laparoscopic group = 37/99 (39.9%) versus the open group = 71/114 (62.3%); RR 0.64; 95% CI 0.48 to 0.86; participants = 213;
studies = 3; I² = 0%); and the median lengths of hospital stay were significantly less in the laparoscopic group than the open group
(three days less in all three studies that reported this outcome; number of participants = 266). There was lack of clarity as to whether
the median difference in the quantity of blood transfused was statistically significant favouring laparoscopic oesophagectomy in the
only study that reported this information. None of the studies reported post-operative dysphagia, health-related quality of life, time-
to-return to normal activity (return to pre-operative mobility without caregiver support), or time-to-return to work.
Authors’ conclusions
There are currently no randomised controlled trials comparing laparoscopic with open transhiatal oesophagectomy for patients with
oesophageal cancers. In observational studies, laparoscopic transhiatal oesophagectomy is associated with fewer overall complications
and shorter hospital stays than open transhiatal oesophagectomy. However, this association is unlikely to be causal. There is currently
no information to determine a causal association in the differences between the two surgical approaches. Randomised controlled trials
comparing laparoscopic transhiatal oesophagectomy with other methods of oesophagectomy are required to determine the optimal
method of oesophagectomy.
P L A I N L A N G U A G E S U M M A R Y
Key-hole (laparoscopic) versus standard cut (open) abdominal surgery for people with food-pipe (oesophageal) cancer
Review question
How does key-hole (laparoscopic) abdominal surgery compare to standard (open) abdominal surgery for people with food-pipe
(oesophageal) cancer?
Background
The oesophagus (food pipe) is locatedmainly in the chest; it enters the abdomen (tummy) through an opening in the diaphragm (muscle
that separates the chest from the abdomen). Removing tumours by surgery (oesophagectomy) is one of the recommended treatments
for cancers that are limited to the oesophagus. The tumour can be removed through an abdominal opening, a chest opening, or a
combination. When the tumour is removed through an abdominal opening, it is called transhiatal oesophagectomy (as the oesophagus
is separated from its surrounding structures through the opening in the diaphragm). The abdominal surgery can be performed through
either a key-hole or a standard cut. Key-hole surgery to remove oesophageal cancer (laparoscopic transhiatal oesophagectomy) is a
relatively new procedure compared to the well-established standard cut surgery (open transhiatal oesophagectomy). In operations on
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other parts of the body, laparoscopic surgery has been shown to reduce complications and length of hospital stays compared to open
surgery.
However, concerns remain about the safety of laparoscopic surgery.Howdo complications after operation (post-operative complications)
compare between the two procedures? Does laparoscopic surgery remove the same amount of cancer and healthy border tissue as open
surgery? Do people recovery more quickly after laparoscopic or open surgery? We sought to resolve these issues by searching the medical
literature for studies on this topic.
Study characteristics
Randomised controlled trials are the best types of studies to find out whether one treatment is better than another since it ensures
that similar types of people receive the new and the old treatment. But we did not find randomised controlled trials; we identified six
relevant non-randomised studies with a total of 334 patients, which compared laparoscopic and open surgeries. Since one of the studies
did not provide usable results, five studies, with 326 patients, provided information for this review; laparoscopic surgery = 151 patients
and open surgery = 175 patients. In four of these studies, historical information was collected from hospital records. In one study, new
information was collected. In general, new information is considered to be more reliable than information from hospital records.
Key results
The differences between laparoscopic and open transhiatal oesophagectomy were imprecise for: deaths during the short-term and long-
term, the percentage of people with major complications, narrowing of the new junction between the gut, created after removing the
oesophagus, cancer returning during the short-term and long-term, and the proportion of people who required blood transfusion. The
proportion of patients with any complications and the average lengths of hospital stay were less in the key-hole group than the open cut
group. There was lack of clarity about the difference in the amount of blood transfused between the two groups. None of the studies
reported difficulty in swallowing after surgery, health-related quality of life, the amount of time it took to return to normal activity
(same mobility as before surgery), or work.
Quality of the evidence
The quality of the evidence was very low. This was mainly because it was not clear whether participants who received laparoscopic
surgery were similar to those who had open surgery. This makes the findings unreliable. Well-designed randomised controlled trials are
necessary to obtain high-quality evidence on the best method to perform oesophagectomy.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer
Patient or population: pat ients with oesophageal cancer
Settings: upper gastrointest inal surgery unit
Intervention: laparoscopic transhiatal oesophagectomy
Control: open transhiatal oesophagectomy
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Assumed risk Corresponding risk
Open transhiatal
oesophagectomy
Laparoscopic transhiatal
oesophagectomy
Short- term mortality
(in hospital or within 3
months)
11 per 1000 5 per 1000
(1 to 47)
RR 0.44
(0.05 to 4.09)
326
(5 studies)
⊕©©©
very low1,2,3
Long- term mortality
Follow-up: median 2 years
355 per 1000 346 per 1000
(299 to 398)
HR 0.97
(0.81 to 1.16)
193
(2 studies)
⊕©©©
very low1,3
Serious adverse events
(proportion)
211 per 1000 103 per 1000
(51 to 208)
RR 0.49
(0.24 to 0.99)
213
(3 studies)
⊕©©©
very low1,3
Anastomotic stenosis 81 per 1000 111 per 1000
(27 to 462)
RR 1.37
(0.33 to 5.7)
73
(1 study)
⊕©©©
very low1,2,3
None of the studies reported post-operative dysphagia or health- related quality of life.
* The basis for the assumed risk was the mean control group proport ion. The corresponding risk (and its 95% conf idence interval) is based on the assumed risk in the
comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: Conf idence interval; RR: Risk rat io; HR: Hazard rat io.
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Risk of bias was unclear or high in the study/ studies.
2 The conf idence intervals were wide (overlapped clinically signif icant ef fects and no ef fect).
3 The sample size was small.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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B A C K G R O U N D
Description of the condition
Oesophageal cancer (squamous cell carcinoma and adenocarci-
noma) is the ninth most common cancer and the sixth most com-
mon cause of cancer-related mortality in the world (IARC 2014).
In 2012, there were about 455,000 new people diagnosed with
oesophageal cancer and 400,000 deaths due to oesophageal cancer
globally (IARC 2014). There is global variation in the incidence
of oesophageal cancers, with an age-standardised annual incidence
rate of 17 to 24 per 100,000 population in parts of Eastern Africa,
such as Malawi and Kenya, parts of Central Asia (Turkmenistan)
and East Asia (Mongolia), compared with an age-standardised an-
nual incidence rate of less than 1 per 100,000 population in parts
ofWestern Africa (Nigeria, Guinea, Guinea-Bissau) (IARC 2014).
The trend in mortality is similar, with an age-standardised annual
mortality rate of 16 to 23 per 100,000 population in the countries
with a high incidence and less than 1 per 100,000 population in
the countries with a low incidence (IARC 2014). In the UK, there
was an increase in the incidence of oesophageal cancer in men and
a decrease in the incidence in women from 2001 to 2011 (Cancer
Research UK 2014).
The treatment of oesophageal cancer depends upon the stage of
cancer. One of the common systems for staging cancer is the 7th
edition of the American Joint Committee on Cancer (AJCC) oe-
sophageal cancer staging system (AJCC 2010; Rice 2010). This
system is based on TNM classification: tumour (T) involvement
of the different layers of the stomach, nodal involvement (N), the
presence of metastases (M), plus grade of the tumour (G), and
histological type (squamous cell carcinoma or adenocarcinoma;
AJCC 2010; Rice 2010; Stahl 2013). The TNM-G that consti-
tutes the stage of the cancer is dependent upon the histological
type (AJCC 2010; Rice 2010). Metastatic oesophageal cancer cor-
responds to Stage IV of the AJCC oesophageal cancer staging sys-
tem, regardless of the presence or absence of the other factors.
The survival after diagnosis of oesophageal cancer depends upon
the stage with five-year survival ranging from 70% in Stage Ia
squamous cell carcinoma and 80% in Stage Ia adenocarcinoma
to 15% in Stage IV squamous cell carcinoma or adenocarcinoma
(AJCC 2010; Rice 2010). Potentially curative chemoradiotherapy
is currently advocated only in people with localised cancer of the
oesophagus who are unfit for surgery (Stahl 2013), or in patients
with localised squamous cell carcinoma (Allum 2011). Endoscopic
resection of squamous cell carcinoma or adenocarcinoma is a vi-
able first-line treatment option in people with localised T-1a tu-
mours (Fovos 2012; Stahl 2013). When the person is fit, surgery
is the preferred curative option in the treatment of oesophageal
cancer, according to the European Society for Medical Oncology
guidelines (Stahl 2013). According to the guidelines from the As-
sociation of Upper Gastrointestinal Surgeons of Great Britain and
Ireland, the British Society of Gastroenterology, and the British
Association of Surgical Oncology, definitive chemoradiotherapy is
the preferred option in the treatment of localised squamous cell
carcinoma of the upper third of oesophagus, and an equivalent op-
tion to surgery for the treatment of localised squamous cell carci-
noma of the middle and lower third of oesophagus (Allum 2011).
Description of the intervention
One of major controversies, and a topic of ongoing debate in
oesophagectomy, iswhether oesophagectomy should be performed
by the transthoracic route or the transhiatal route (Boshier 2011;
Colvin 2011; Omloo 2007).
Broadly, transhiatal oesophagectomy involves mobilisation of the
lower end of the oesophagus from the abdomen and mobilisation
of the cervical oesophagus from the neck. Once the oesophagec-
tomy is competed, restoration of continuity of the gastrointestinal
tract is obtained by anastomosing the cervical oesophagus with
a tube formed from the stomach or colon through the cervical
wound (Orringer 2007).
In open transhiatal oesophagectomy, the surgical access to the ab-
dominal cavity (and hence the lower end of the oesophagus, stom-
ach, and colon) is through an upper midline incision. In laparo-
scopic transhiatal oesophagectomy, the surgical access to the ab-
dominal cavity (and hence the lower end of the oesophagus, stom-
ach, and colon) is through five small ports (holes) of about 0.5 to 1
cm each, through which laparoscopic instruments can be inserted
after the abdomen is distended using carbon-dioxide pneumoperi-
toneum (Avital 2005; Cash 2014; Yamamoto 2013). The entire
abdominal part of the surgery is performed laparoscopically. Peri-
operative chemotherapy or chemoradiotherapy is administered,
depending upon the stage, histological type, and resection margin
status after oesophagectomy (Stahl 2013).
Oesophagectomy may also be performed using a combined ab-
dominal, thoracic, and cervical approach (three-stage approach or
McKeown procedure) (McKeown 1976).
Transthoracic oesophagectomy has more postoperative morbidity
andmortality compared with transhiatal oesophagectomy, and de-
spite no evidence of a statistically significant difference in the five-
year survival between the two methods, transthoracic oesophagec-
tomy is believed to offer a long-term survival advantage over
transhiatal oesophagectomy (Boshier 2011; Colvin 2011; Omloo
2007).
How the intervention might work
For many surgical procedures, laparoscopic surgery is now pre-
ferred over open surgery. This includes surgical procedures such as
cholecystectomy (removal of gallbladder), surgery for colon can-
cer, and hysterectomy. The reason for this preference is decreased
pain, decreased blood loss, shorter hospital stay, earlier postop-
erative recovery, better cosmesis (physical appearance), and de-
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creased costs associated with laparoscopic surgery (Bijen 2009;
Keus 2006; Reza 2006; Talseth 2014; Walsh 2009). In addition to
these generic advantages of laparoscopic surgery, one of the poten-
tial advantages of laparoscopic transhiatal oesophagectomy over
open transhiatal oesophagectomy is the direct visualisation of the
lower mediastinum without blind dissection (Yamamoto 2013).
Why it is important to do this review
While the smaller incision and earlier postoperative recovery ap-
pear to be potential advantages of laparoscopic oesophagectomy,
the safety of a laparoscopic approach for a procedure that has a
high complication rate, and the rate of cancer clearance has to be
ensured before the method can be widely recommended. There
are concerns about cancer clearance since port-site metastases (re-
currence of cancer at the laparoscopic port-site) have been re-
ported after removal of several cancers (e.g. squamous cell carci-
noma of the gallbladder (Kais 2014); endometrial cancer (Palomba
2014); renal cancer (Song 2014)). Animal research has shown that
the increased intra-abdominal pressure during laparoscopy (pneu-
moperitoneum) may drive the malignant cells into the ports, or
the malignant cells may adhere to the laparoscopic instruments
that are introduced and removed through the ports, resulting in
seeding of the port site and port-site metastases (Hopkins 1999).
There is also a concern of the adequacy of cancer clearance in
terms of resection margins and the extent of lymph nodes removed
with laparoscopy. However, one of the potential advantages of
laparoscopic over open transhiatal oesophagectomy, is the direct
visualisation of the lower mediastinum without blind dissection,
which may facilitate a better nodal clearance (and hence oncologi-
cal clearance) (Yamamoto 2013). There appear to be ongoing con-
troversies on the best procedure: laparoscopic or open transhiatal
oesophagectomy. There is no Cochrane review on this topic.
O B J E C T I V E S
To assess the benefits and harms of laparoscopic versus open oe-
sophagectomy for people with oesophageal cancer undergoing a
transhiatal oesophagectomy.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Weplanned to include randomised controlled trials (RCTs) for this
review. However, there were no randomised controlled trials on
this topic. So, we included non-randomised studies to provide the
best available evidence on the topic, along with a critical appraisal
of the existing evidence. We included studies reported as full text,
studies published as abstract only, and unpublished data.
Types of participants
We included adults undergoing transhiatal oesophagectomy (oe-
sophagectomy without thoracotomy with a cervical anastomosis)
for oesophageal cancer (squamous cell carcinoma or adenocarci-
noma). While we excluded people undergoing oesophagectomy
for oesophageal strictures not amenable for endoscopic treatment
or dysplasia whenever possible, we included studies in which no
separate outcome data for people undergoing oesophagectomy for
oesophageal cancers were available, provided that oesophagectomy
for other causes was less than 10% of the participants included in
the study.
Types of interventions
We included studies that compared laparoscopic transhiatal oe-
sophagectomy with open transhiatal oesophagectomy. We ex-
cluded trials that compared thoracoscopic oesophagectomy with
open transthoracic oesophagectomy, or trials that compared min-
imally invasive approaches with open approaches for McKeown’s
procedures.
Types of outcome measures
Primary outcomes
1. Mortality.
i) Short-term mortality (in-hospital mortality or
mortality within three months).
ii) Long-term mortality.
2. Serious adverse events (within three months). We accepted
the following definitions of serious adverse events.
i) Clavien-Dindo classification: Grade III or higher
(Clavien 2009; Dindo 2004).
ii) International Conference on Harmonisation - Good
Clinical Practice (ICH-GCP) guideline (ICH-GCP 1996): we
defined serious adverse events as any untoward medical
occurrence that resulted in death, was life threatening, required
hospitalisation or prolongation of existing hospitalisation, or
resulted in persistent or significant disability or incapacity.
iii) Individual complications that could clearly be
classified as Grade III or higher with Clavien-Dindo
classification, or as a serious adverse event with ICH-GCP
classification.
iv) Postoperative dysphagia (difficulty in swallowing).
v) Anastomotic stenosis.
3. Health-related quality of life (using any validated scale).
i) Short-term (four weeks to three months).
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ii) Medium-term (three months to one year).
Secondary outcomes
1. Recurrence (local recurrence, surgical wound recurrence
(also called port-site metastases in the laparoscopic group) or
distal metastases).
i) Short-term recurrence (within six months).
ii) Long-term recurrence.
2. Adverse events (within three months). We accepted all
adverse events reported by the study author regardless of the
severity of the adverse event.
3. Perioperative blood transfusion requirements (whole blood
or red cell transfusion; during surgery or within one week after
surgery) .
i) Proportion of people requiring blood transfusion.
ii) Quantity of blood transfusion.
4. Measures of earlier postoperative recovery.
i) Length of hospital stay (including the index admission
for oesophagectomy and any surgical complication-related re-
admissions).
ii) Time-to-return to normal activity (return to pre-
operative mobility without additional caregiver support).
iii) time-to-return to work (in people who were previously
employed).
5. Positive resection margins (presence of macroscopic or
microscopic cancer tissue at the plane of resection) at
histopathological examination after surgery.
6. Number of lymph nodes harvested during surgery.
We chose the clinical outcomes to assess whether laparoscopic
surgery resulted in adequate cancer clearance, was safe, and was
beneficial in terms of decreased blood transfusion requirements;
earlier postoperative recovery allowed earlier discharge from hos-
pital, return to normal activity, and return to work; and improve-
ment in health-related quality of life.We highlight that the positive
resection margins at histopathological examination after surgery
and the number of harvested lymph nodes during surgery are sur-
rogate outcomes; we included these in order to explore whether
these are responsible for any differences in survival or mortality.
Studies that met the inclusions criteria were included, regardless
of whether they reported the outcomes of interest.
Search methods for identification of studies
Electronic searches
We conducted a literature search to identify all published and un-
published studies in all languages. We translated any non-English
language papers and fully assessed them for potential inclusion in
the review as necessary.
We search the following electronic databases:
1. the Cochrane Central Register of Controlled Trials
(CENTRAL; 2015, Issue 8; Appendix 1);
2. MEDLINE (1966 to August 2015; Appendix 2);
3. EMBASE (1988 to August 2015; Appendix 3); and
4. Science Citation Index (1982 to August 2015; Appendix 4).
On 14 August 2015, we also conducted a search of ClinicalTri-
als.gov (ClinicalTrials.gov; Appendix 5), and the World Health
Organization - International Clinical Trials Registry Platform
(WHO ICTRP; www.who.int/ictrp/en/; Appendix 6) .
Searching other resources
We checked reference lists of all primary studies and review articles
for additional references. We also contacted authors of identified
trials and asked them to identify other published and unpublished
studies.
On 16 November 2015, we searched for errata or retractions from
eligible trials on PubMed (www.ncbi.nlm.nih.gov/pubmed).
Data collection and analysis
Selection of studies
Three review authors (KG, EP, SM) independently screened titles
and abstracts for inclusion. We coded them as ’retrieve’ (eligible
or potentially eligible or unclear) or ’do not retrieve’. We retrieved
the full-text study reports for references coded as ’retrieve’. Three
review authors (KG, EP, SM) independently screened the full text,
identified studies for inclusion, and identified and recorded reasons
for those we excluded. We resolved any disagreements through
discussion. We identified and excluded duplicates and collated
multiple reports of the same study so that each study, rather than
each report, was the unit of interest in the review. We recorded the
selection process in sufficient detail to complete a PRISMA flow
diagram and Characteristics of excluded studies table.
Data extraction and management
We used a standard data collection form for study characteris-
tics and outcome data that was piloted on at least one study
in the review. Three review authors (KG, EP, SM) extracted
study characteristics from included studies and detailed them in a
Characteristics of included studies table. We extracted the follow-
ing study characteristics:
1. methods: study design, total duration of the study and run-
in, number of study centres and location, study setting,
withdrawals, date of study;
2. participants: number, mean age, age range, gender, tumour
stage, tumour location, histological subtype, performance status,
American Society of Anesthesiologists (ASA) status (ASA 2014),
inclusion criteria, exclusion criteria;
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3. interventions: intervention, comparison, concomitant
interventions;
4. outcomes: primary and secondary outcomes specified and
collected, time points reported;
5. notes: funding for trial, notable conflicts of interest of trial
authors.
Three review authors (KG, EP, SM) independently extracted out-
come data from included studies. If outcomes were reported mul-
tiple times for the same time frame (e.g. short-term health-related
quality of life reported at six weeks and three months), we had
planned to choose the later time point (i.e. three months) for data
extraction. For time-to-event outcomes where data were censored,
we extracted data to calculate the natural logarithm of the hazard
ratio (HR) and its standard error using the methods suggested by
Parmar, et al. (Parmar 1998).
We included all participants for long-term outcomes (e.g. mortal-
ity or quality of life), which were not conditional upon the short-
term outcomes (e.g. being alive at three months or having a low
or high quality-of-life index at three months).
We noted under each outcome if outcome data were reported in an
unusableway in one ormore studies.We resolved disagreements by
consensus. One review author (KG) copied the data from the data
collection form into the Review Manager 5 (RevMan 2014). We
double checked that the data were entered correctly by comparing
the study reports with the data in the systematic review.
Assessment of risk of bias in included studies
Three review authors (KG, EP, SM) independently assessed the
risk of bias for each study. We had planned to use the criteria out-
lined in the Cochrane Handbook for Systematic Reviews of Interven-
tions (Higgins 2011). However, because of the lack of randomised
controlled trials on the topic, we used the relevant risk of bias do-
mains from ’A Cochrane Risk Of Bias Assessment Tool: for Non-
Randomized Studies of Interventions’ (ACROBAT-NRSI; Sterne
2014).
We assessed the risk of bias according to the following domains:
1. Bias due to confounding
2. Bias due to the selection of participants
3. Bias due to departures from intended intervention
4. Bias in the measurement of outcomes
5. Bias due to missing data
6. Bias in selection of the reported findings
We resolved any disagreements by discussion.
We graded each potential source of bias as critical, serious, moder-
ate, low, or no information, and provided a quote from the study
report together with a justification for our judgement in the ’Risk
of bias’ table. We summarised the risk of bias judgements across
different studies for each of the domains listed. Where informa-
tion on risk of bias relates to unpublished data or correspondence
with a trialist, we noted this in the ’Risk of bias’ table.
When considering treatment effects, we took the risk of bias for
the studies that contributed to that outcome into account.
Assessment of bias in conducting the systematic
review
We conducted the review according to the published protocol and
reported any deviations from it in the relevant sections and in the
’Differences between protocol and review’ section of the systematic
review.
Measures of treatment effect
We analysed dichotomous data as risk ratio (RR) and continuous
data as mean difference (MD) when the outcome was reported, or
we converted to the same units in all the trials (e.g. hospital stay,
time to return to work); we had planned to calculate the standard-
ised mean difference (SMD) when different scales were used for
measuring the outcome (e.g. quality of life). We had planned: to
ensure that higher scores for continuous outcomes had the same
meaning for the particular outcome, to explain the direction to
the reader, and to report where the directions were reversed if this
was necessary. We had planned to calculate the rate ratio (RaR)
for outcomes such as adverse events and serious adverse events,
where it was possible for the same person to develop more than
one adverse event (or serious adverse event). If the authors had cal-
culated the RaR of adverse events (or serious adverse events) in the
intervention versus control based on Poisson regression, we had
planned to use the Poisson regression method to obtain the RaR
in preference to calculating the RaR with the number of adverse
events (or serious adverse events) during a certain period. We cal-
culated the Hazard Ratio (HR) for time-to-event outcomes such
as long-term mortality, long-term recurrence, and had planned to
calculate the HR for time-to-first adverse event (or serious adverse
event) if the information was reported in this manner.
We undertook meta-analyses since this was meaningful (i.e. the
treatments, participants, and the underlying clinical question were
similar enough to pool).
A common way that trialists indicate when they have skewed data
is by reporting medians and interquartile ranges. When we en-
countered this, we noted that the data were skewed by following
the rough guide for identifying skewed distribution available in
Higgins 2011 and considered the implication of this.
Where multiple trial arms were reported in a single trial, we had
planned to include only the relevant arms. If we had entered two
comparisons (e.g. laparoscopic oesophagectomy method 1 versus
open oesophagectomy and laparoscopic oesophagectomy method
2 versus open oesophagectomy) into the same meta-analysis, we
had planned to halve the control group to avoid double counting.
The alternative way of including trials with multiple arms is to
pool the results of the laparoscopic oesophagectomymethod 1 and
laparoscopic oesophagectomy method 2 and compare the pooled
results with open oesophagectomy. We had planned to perform a
sensitivity analysis to determine if the results of the two methods
of dealing with multi-arm trials lead to different conclusions.
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Unit of analysis issues
The unit of analysis was the individual participant undergoing
transhiatal oesophagectomy. As expected, we did not find any clus-
ter-randomised trials for this comparison. If we had identified
cluster-randomised trials, we would have obtained the effect esti-
mate adjusted for the clustering effect. If this was not available,
we would have performed a sensitivity analysis excluding the trial
from the meta-analysis, as the variance of the estimate of effect
unadjusted for the cluster effect is less than the actual variance
that is adjusted for the cluster-effect, giving inappropriately more
weight to the cluster RCT in the meta-analysis.
Dealing with missing data
We contacted investigators or study sponsors in order to verify
key study characteristics and obtain missing numerical outcome
data where possible (e.g. when a study was identified as an ab-
stract only). If we were unable to obtain the information from
the investigators or study sponsors, we imputed a mean from the
median (i.e. considered the median as the mean) and calculated
a standard deviation from the standard error, interquartile range,
or P values, and assessed the impact of including such studies in
a sensitivity analysis, according to the Cochrane Handbook for Sys-
tematic Reviews of Interventions (Higgins 2011). If we had been
unable to calculate the standard deviation from the standard error,
interquartile range, or P values, we had planned to impute a stan-
dard deviation from the highest standard deviation in the remain-
ing trials included in the outcome, fully aware that this method of
imputation would decrease the weight of the studies in the meta-
analysis of MD, and shift the effect towards no effect for SMD.
Assessment of heterogeneity
We used the I² statistic to measure heterogeneity among the tri-
als in each analysis. If we identified substantial heterogeneity as
per the Cochrane Handbook for Systematic Reviews of Interventions
(greater than 50% to 60%), we explored it by pre-specified sub-
group analyses (Higgins 2011).
Assessment of reporting biases
We attempted to contact study authors to ask them to provide
missing outcome data. Had this not been possible, and themissing
data were thought to introduce serious bias, we had planned to
explore the impact of including such studies in the overall assess-
ment of results, using a sensitivity analysis.
If we had been able to pool more than 10 trials, we had planned to
create and examine a funnel plot to explore possible publication
biases. We had planned to use Egger’s test to determine the statisti-
cal significance of the reporting bias (Egger 1997).We would have
considered a P value less than 0.05 to be a statistically significant
reporting bias.
Data synthesis
We performed analyses using Review Manager 5 (RevMan 2014).
We calculated the 95% confidence intervals(CI) for the treatment
effect. We used the Mantel-Haenszel method for dichotomous
data, inverse-variance method for continuous data, and generic-
inverse variance for time-to-event data. We had planned to use the
inverse-variance method for count data. We used both the fixed-
effect and random-effects model for the analyses (Demets 1987;
DerSimonian 1986). In the case of discrepancy between the two
models, we reported both results; otherwise we reported only the
results from the fixed-effect model.
’Summary of findings’ table
We created a ’Summary of findings’ table using all the outcomes.
We used the five GRADE considerations (study limitations, con-
sistency of effect, imprecision, indirectness, and publication bias)
to assess the quality of the body of evidence as it related to the
studies that contributed data to themeta-analyses for the pre-spec-
ified outcomes. We used the methods and recommendations de-
scribed in Section 8.5 and Chapter 12 of the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011), and using
GRADEpro software. We justified all decisions to downgrade or
upgrade the quality of the evidence in the footnotes and make
comments to aid the reader’s understanding of the review where
necessary. We considered whether there was additional outcome
information that we were unable to incorporate into the meta-
analyses, noted this in the comments, and stated whether it sup-
ported or contradicted the information from the meta-analyses.
Subgroup analysis and investigation of heterogeneity
We had planned to carry out the following subgroup analyses:
1. different histological types (squamous cell carcinoma and
adenocarcinoma);
2. different cancer stages;
3. different locations (upper third, middle third, lower third);
4. people with different anaesthetic risk (ASA I (a healthy
person) or II (a person with mild systemic disease) versus ASA III
or more (a person with severe systemic disease or worse);
5. different body mass index (BMI): healthy weight (BMI
18.5 to 25) versus overweight or obese (BMI 25 or greater).
We had planned to use all the primary outcomes in subgroup
analyses.
We had planned to use the formal Chi² test for subgroup differ-
ences to test for subgroup interactions.
Sensitivity analysis
We had planned to perform sensitivity analyses defined a priori
to assess the robustness of our conclusions. These would have
involved:
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1. excluding trials at unclear or high risk of bias (one or more
of the risk of bias domains (other than blinding of surgeon)
classified as unclear or high);
2. excluding trials in which either mean or standard deviation,
or both are imputed;
3. excluding cluster RCTs in which the adjusted effect
estimates are not reported;
4. different methods of dealing with multi-arm trials (see
Measures of treatment effect).
Reaching conclusions
Webased our conclusions only onfindings from the quantitative or
narrative synthesis of included studies for this review. We avoided
making recommendations for practice, and our implications for
research have given the reader a clear sense of where the focus of
any future research in the area should be and what the remaining
uncertainties are.
R E S U L T S
Description of studies
Results of the search
We identified 3069 references through electronic searches of
Cochrane Central Register of Controlled Trials (CENTRAL; (Wi-
ley); N = 28),MEDLINE (OvidSP;N =762), EMBASE (OvidSP;
N = 1659), Science Citation Index expanded (N = 604), Clini-
calTrials.gov (N = 9) and WHO Trials register (N = 7). After re-
moving duplicate references, there were 1965 remaining. We ex-
cluded1930 clearly irrelevant references through reading abstracts.
We retrieved the full publication of 35 references for further de-
tailed assessment. We excluded 24 studies (25 references) for the
reasons listed in the Characteristics of excluded studies. Six non-
randomised studies (10 references) fulfilled the inclusion criteria
(Characteristics of included studies). The reference flow is shown
in Figure 1.
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Figure 1. Study flow diagram.
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Included studies
We included a total of six non-randomised studies (Badessi 2003;
Cash 2014; Ecker 2015; Maas 2012; Saha 2009; Valenti 2008).
Five studies were retrospective studies (Badessi 2003; Cash 2014;
Ecker 2015; Maas 2012; Saha 2009), while one of the stud-
ies was a prospective study (Valenti 2008). All studies were sin-
gle institutional studies. Two studies compared laparoscopic oe-
sophagectomy with historical controls who underwent open oe-
sophagectomy (Cash 2014; Maas 2012). Three studies compared
laparoscopic oesophagectomy with contemporary controls who
underwent openoesophagectomy (Ecker 2015; Saha2009;Valenti
2008). It was not clear whether one of the studies was a case-con-
trol study or a cohort study (Badessi 2003).
One study included only patients with adenocarcinoma (Saha
2009). Three studies included a mixture of adenocarcinoma and
squamous cell carcinoma but did not report the outcome data
separately (Ecker 2015; Maas 2012; Valenti 2008). Two stud-
ies did not report the histological types of cancer (Badessi 2003;
Cash 2014). One study included Stage I cancer only (Saha 2009).
Three studies included Stages I to III cancer but did not report
the outcome data separately for different stages (Cash 2014; Ecker
2015; Maas 2012). Two studies did not report the stages of can-
cer (Badessi 2003; Valenti 2008). Three studies indicated that the
location of cancer was in the lower third (Maas 2012; Saha 2009;
Valenti 2008). Information on the location of the tumours was
not available in the remaining three studies. One study included
patients with ASA I to III (Maas 2012). One study included pa-
tients with ASA I to IV; one patient in each group belonged to
ASA IV category, while the remaining patients belonged to ASA
I to III (Valenti 2008). Neither study reported outcome data sep-
arately for the different ASA stages. Information on ASA was not
available in the remaining four studies. There was no restriction
based on BMI in any of the studies. None of the studies reported
the outcome data separately for healthy weight versus overweight
or obese patients.
Five ports were used to perform laparoscopic oesophagectomy in
all three studies that provided information on the number of ports
(Maas 2012; Saha 2009; Valenti 2008). The remaining studies
did not provide this information. A mini-laparotomy of 7 cm was
used to perform the anastomosis and retrieve the specimen in two
studies that reported this information (Maas 2012; Valenti 2008).
The remaining studies did not provide this information. None of
the studies reported the size of incision in the open oesophagec-
tomies. Drain use was not stated in either group, in any of the stud-
ies. The proportion of patients that were converted from laparo-
scopic to open oesophagectomy was 2/33 (6.1%), 4/36 (11.1%),
9/50 (18%), and 0/16 (0%) respectively, in the four studies that
reported this information (Cash 2014; Ecker 2015; Maas 2012;
Valenti 2008).
A total of 334 patients underwent laparoscopic (154 patients)
or open (180 patients) transhiatal oesophagectomy. One study,
which included eight patients, did not report any outcomes of
interest for this review. Excluding this study, a total of 326 patients,
undergoing laparoscopic (151 patients) or open (175 patients)
transhiatal oesophagectomy, contributed to one or more outcomes
in this review. The mean or median age in the studies ranged
from 64 years to 74 years in the five studies that reported this
information (Cash 2014; Ecker 2015; Maas 2012; Saha 2009;
Valenti 2008). All the studies reported the proportion of females,
which ranged from 20% to 37.5%.
The follow-upperiodwas not stated in three studies (Badessi 2003;
Maas 2012; Valenti 2008). The median follow-up period in the
remaining studies were as follows.
• Cash 2014: 26 months for the laparoscopic
oesophagectomy group and 64 months for the open
oesophagectomy group (survival at 24 months was used to
calculate proportion survived)
• Ecker 2015: 10 months
• Saha 2009: 44 months
The outcomes reported in the studies are summarised in
Characteristics of included studies.
Excluded studies
Two studies were rejected because they includedmore than 10%of
patients without cancer, but separate outcome data were not avail-
able for patients with cancer (Bernabe 2005; Perry 2009). Eight
studies were excluded because the patients did not undergo laparo-
scopic transhiatal oesophagectomy (Blazeby 2011; Burdall 2015;
Csendes 2013; Dolan 2013; Parameswaran 2013; Safranek 2010;
Schoppmann 2010; Yamasaki 2011). One study was excluded be-
cause it was not clear whether patients underwent transhiatal oe-
sophagectomy (Harrison 2013). One study was excluded because
there was no control group of open oesophagectomy (Scheepers
2008). Six studies were excluded because separate data were not
available for patients who underwent transhiatal oesophagectomy
(Bresadola 2006; Fabian 2008; Kang 2013; Mamidanna 2012;
Mao 2012; Messenger 2015). The remaining six studies were ex-
cluded because they were not primary research (e.g. review, edi-
torial, letter to editor, comment, or cost-effectiveness study with
no primary research data; Cuesta 2012; Ferreira 2004; Lee 2013;
Mariette 2012; Rice 2012; Ujiki 2013).
Risk of bias in included studies
Bias due to confounding
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There was no information for the risk of bias due to confounding
for five studies (Badessi 2003; Ecker 2015;Maas 2012; Saha 2009;
Valenti 2008). Although four studies reported that there were no
baseline differences between the groups, the studies were not pow-
ered to measure the baseline differences, and did not assess the
baseline difference for one or more confounding factors (Ecker
2015; Maas 2012; Saha 2009; Valenti 2008). In one study, the tu-
mour size was smaller in patients undergoing laparoscopic surgery,
although the proportion of patients who underwent neo-adjuvant
therapy was more in the laparoscopic surgery group (Cash 2014).
This is likely to have introduced critical bias to the estimates of
effect.
Bias due to the selection of participants
Two studies used historical controls (Cash 2014; Maas 2012). In
these two studies, after a certain date, the authors only performed
laparoscopic oesophagectomy, and compared the results of laparo-
scopic oesophagectomy with those of open oesophagectomy be-
fore this date. We considered these studies to have moderate risk
of bias. In two studies, the decision to perform laparoscopic or
open oesophagectomy was based on the surgeon’s preference (Saha
2009;Valenti 2008).We classified these studies as providing ’no in-
formation’. The criteria used to perform oesophagectomy or open
oesophagectomy was not stated in the remaining studies (Badessi
2003; Ecker 2015). We also classified these studies as providing
’no information’.
Bias due to departures from intended intervention
None of the studies reported whether the patient care other than
laparoscopic or open procedure was identical in the two groups.
We classified all studies as providing ’no information’.
Bias in the measurement of outcomes
Three studies clearly reported that the outcome assessors were
not blinded (Maas 2012; Saha 2009; Valenti 2008). This might
have introduced bias in the measurement of outcomes other than
mortality. We considered these studies to have critical risk of bias.
The information on outcome assessor blinding was not reported
in the remaining studies (Badessi 2003; Cash 2014; Ecker 2015).
We considered these studies as providing ’no information’.
Bias due to missing data
Four studies included all the patients who met the inclusion cri-
teria; we considered them to be at low risk of bias due to missing
data (Ecker 2015; Maas 2012; Saha 2009; Valenti 2008). It was
not clear whether any patients were excluded from analysis in the
remaining two studies (Badessi 2003; Cash 2014). We considered
these studies as providing ’no information’.
Bias in selection of the reported findings
Only two studies reportedmortality andmorbidity adequately and
could be considered at low risk of bias due to selective outcome
reporting (Cash 2014; Maas 2012). We considered one study to
be at critical risk of bias since neither mortality nor morbidity
was reported (Badessi 2003).We considered the remaining studies
to be at serious risk of bias as morbidity was not reported, since
one would expect studies comparing laparoscopic with open oe-
sophagectomy to report the data on mortality and morbidity in a
detailed manner (Ecker 2015; Saha 2009; Valenti 2008).
Effects of interventions
See: Summary of findings for the main comparison
Laparoscopic versus open transhiatal oesophagectomy for
oesophageal cancer: primary outcomes; Summary of findings
2 Laparoscopic versus open transhiatal oesophagectomy for
oesophageal cancer: secondary outcomes
None of the studies reported post-operative dysphagia, health-
related quality of life, time-to-return to normal activity (return
to pre-operative mobility without additional caregiver support),
or time-to-return to work. The effects of interventions are sum-
marised in the Summary of findings for the main comparison and
Summary of findings 2.
Mortality
Five studies reported short-term mortality (Cash 2014; Ecker
2015; Maas 2012; Saha 2009; Valenti 2008). There was no statis-
tically significant difference in the short-term mortality between
the two groups (laparoscopic group: 0/151 (adjusted proportion
based on meta-analysis estimate: 0.5%) versus open group: 2/175
(1.1%); Risk Ratio (RR) 0.44; 95% CI 0.05 to 4.09; participants
= 326; studies = 5; I² = 0%; Analysis 1.1). There was no change
in results when we used a random-effects model.
Two studies reported long-termmortality between the two groups
(Cash 2014;Maas 2012). There was no statistically significant dif-
ference in the long-term mortality between the two groups (Haz-
ard Ratio (HR) 0.97; 95% CI 0.81 to 1.16; participants = 193;
studies = 2; I² = 0%; Analysis 1.2). The two-year mortality was
30% and 35% in the laparoscopic and open groups respectively
in Cash 2014, while the three-year mortality was 64% and 62%
in the laparoscopic and open groups respectively in Maas 2012.
There was no change in results when we used a random-effects
model. In addition to the two studies included in the meta-anal-
ysis, two other studies reported the mortality at the maximum
follow-up (Ecker 2015; Saha 2009). However, we did not include
these studies in the meta-analysis since there were no deaths af-
ter a median follow-up of 10 months in the laparoscopic group
(0/36) versus 6% dead in the open group (absolute numbers not
available) in Ecker 2015, and no deaths after a median follow-up
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of 44 months in the open group (0/4) versus 1/16 (6.3%) dead in
laparoscopic group in Saha 2009.
Serious adverse events
Three studies reported the proportion of patients with serious ad-
verse events (Cash 2014;Maas 2012; Saha 2009). The proportion
of people with adverse events was statistically significantly lower
in the laparoscopic group (10/99; adjusted proportion: 10.3%)
compared to the open group (24/114 (21.1%); RR 0.49; 95% CI
0.24 to 0.99; participants = 213; studies = 3; I² = 0%; Analysis
1.3). There was no change in results when we used a random-
effects model.
Details of the serious adverse events were not available in Cash
2014. The serious adverse events in the other studies included
complications which required re-operations, such as re-inspection
of anastomosis, revision of anastomosis, and tracheal repair in
Maas 2012, and anastomotic leaks in the Saha 2009.
Ecker 2015 reported anastomotic stenosis. There was no statisti-
cally significant difference in the proportion of people with anas-
tomotic stenosis between the two groups (laparoscopic group: 4/
36 (11.1%) versus open group: 3/37 (8.1%); RR 1.37; 95% CI
0.33 to 5.70; participants = 73; studies = 1; Analysis 1.4). Since
there was only one study for this outcome, the issue of fixed-effect
versus random-effects model did not arise.
None of the studies reported post-operative dysphagia.
Health-related quality of life
None of the studies reported health-related quality of life at any
time frame.
Recurrence
Saha 2009 reported short-term recurrence within six months.
There was no statistically significant difference in the proportion
of people with short-term recurrence between the two groups (la-
paroscopic group: 1/16 (6.3%) versus open group: 0/4 (0%); RR
0.88; 95%CI0.04 to 18.47; participants = 20; studies = 1; Analysis
1.5). Since there was only one study for this outcome, the issue of
fixed-effect versus random-effects model did not arise.
Two studies reported long-term recurrence (Ecker 2015; Maas
2012). There was no statistically significant difference in the long-
term recurrence between the two groups (HR 1.00; 95% CI 0.84
to 1.18; participants = 173; studies = 2; Analysis 1.6). The 10-
month recurrence was 20% and 24% in the laparoscopic and open
groups respectively in Ecker 2015, while the three-year recurrence
was 69% and 70% in the laparoscopic and open groups respec-
tively, and the five-year recurrence was 77% and 79% in the la-
paroscopic and open groups respectively inMaas 2012. There was
no change in results when we used a random-effects model. We
excluded two other studies from the meta-analysis (Cash 2014;
Saha 2009). In Cash 2014, recurrence at the maximum follow-up
was 8/33 (24.2%) in the laparoscopic group and 15/60 (25%) in
the open group. However, the patients in the laparoscopic group
were followed for amedian period of 26months, while those in the
open group were followed up for a median period of 64 months.
So, it was inappropriate to compare the two proportions. In Saha
2009, there were no recurrences after a median follow-up of 44
months in the open group (0/4) versus 1/16 (6.3%) recurrence in
the laparoscopic group.
Adverse events
Three studies reported the proportion of patients with adverse
events (Cash 2014; Maas 2012; Saha 2009). The proportion of
people with adverse events was statistically significantly lower in
the laparoscopic group (37/99 (39.9%) compared to the open
group (71/114 (62.3%); RR 0.64; 95% CI 0.48 to 0.86; partic-
ipants = 213; studies = 3; I² = 0%; Analysis 1.7). There was no
change in results whenwe used a random-effectsmodel.One other
study reported that the number of complications were fewer in
the laparoscopic group compared to the open group, without pro-
viding information on the complications or statistical significance
(Badessi 2003).
Perioperative blood transfusion requirements
One study reported the proportion of people who required peri-
operative transfusion (Ecker 2015). There was no statistically sig-
nificant difference in the proportion of people who required peri-
operative transfusion between the two groups (laparoscopic group:
0/36 (0%) versus open group: 6/37 (16.2%); RR 0.08; 95% CI
0.00 to 1.35; participants = 73; studies = 1; Analysis 1.8). Since
there was only one study for this outcome, the issue of fixed-effect
versus random-effects model did not arise.
One study reported the quantity of blood transfused (Cash 2014).
The median blood transfused was 0 in the laparoscopic group
compared to 2.5 units in the open group (Analysis 1.9). The sta-
tistical significance was not clear since the P value presented in this
study was for the comparison of three groups (only two of which
were eligible for this review).
Measures of earlier postoperative recovery
Three studies reported the length of hospital stay (Cash 2014;
Ecker 2015; Maas 2012). All three studies reported the median
length of hospital stay so we did not perform a meta-analysis. The
median length of hospital stay was statistically significantly lower
by three days in the laparoscopic group over the open group in all
three studies (Analysis 1.10). One other study reported that the
post-operative hospital stay was shorter in the laparoscopic group
compared to the open group without providing information on
the length of hospital stay or statistical significance (Badessi 2003).
None of the studies reported time-to-return to normal activity or
time-to-return to work.
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Positive resection margins
Three studies reported the proportion of patients with positive
resection margins (Ecker 2015; Maas 2012; Valenti 2008). There
was no statistically significant difference in the proportion of peo-
ple with positive resection margins between the two groups (la-
paroscopic group: 15/102 (adjusted proportion: 15.8%) versus
open group: 27/111 (24.3%); RR 0.65; 95% CI 0.37 to 1.12;
participants = 213; studies = 3; I² = 0%; Analysis 1.11). There was
no change in results when we used the random-effects model.
Number of lymph nodes harvested during surgery
Five studies reported the number of lymph nodes harvested during
surgery (Cash 2014; Ecker 2015; Maas 2012; Saha 2009; Valenti
2008). Since four studies reported the median number of lymph
nodes harvested during surgery, we didnot performameta-analysis
(Cash 2014; Ecker 2015; Maas 2012; Saha 2009). Three studies
reported that there was no statistically significant difference in the
mean or median number of lymph nodes harvested during surgery
(Ecker 2015; Maas 2012; Valenti 2008). One study did not report
whether the median difference in lymph nodes harvested during
surgery was statistically significant (Saha 2009). In the last study,
the statistical significance was not clear, since the P value presented
in this study was for the comparison of three groups (only two of
which were included in this review; Cash 2014; Analysis 1.12).
Assessment of heterogeneity
There was no evidence of heterogeneity demonstrated by the I²
statistic, the Chi² test for heterogeneity, or by visual inspection of
forest plots to identify overlapping confidence intervals, for any of
the outcomes for which we performed a meta-analysis.
Assessment of reporting biases
We did not assess reporting biases using a funnel plot because we
found fewer than 10 studies. There was some evidence of selective
outcome reporting, as shown in the Characteristics of included
studies.
Subgroup analysis
Different histological types (squamous cell carcinoma and
adenocarcinoma)
One study included only patients with adenocarcinoma (Saha
2009). The remaining studies either did not report the histological
type of cancer or did not report the outcome data separately for
the adenocarcinoma or squamous cell carcinoma. The same trial
that included only patients with adenocarcinoma also included
patients with Stage I cancer (Saha 2009). The remaining studies
either did not report the stage of cancer or did not report the
outcome data separately for different stages. So, only one trial
(Saha 2009) was included for the subgroup of adenocarcinoma
and Stage I cancer. There was no mortality in either group and
there was no statistically significant difference in the proportion
of people with serious adverse events (RR 0.50; 95% CI 0.06 to
4.23; participants = 20; studies = 1; Analysis 2.2).
Since there were no other subgroups, we did not use the formal
Chi² test to test for subgroup interactions.
Different cancer locations
Three studies indicated that the location of cancer was in the lower
third (Maas 2012; Saha 2009; Valenti 2008). Information on the
location of tumours was not available in the remaining three stud-
ies (Badessi 2003; Cash 2014; Ecker 2015). A subgroup analysis
of the studies that included lower-third cancers showed no statis-
tically significant difference between the groups in terms of short-
termmortality, long-termmortality, or proportion of patients with
serious adverse events (Analysis 2.2; Analysis 2.3; Analysis 2.4).
Since lower-third cancer was the only subgroup, we did not use
the formal Chi² test to test for subgroup interactions.
Other subgroup analyses
We were unable to perform a subgroup analysis of different anaes-
thetic risk or weights, since the studies either did not report this
information or did not report the outcome data separately for dif-
ferent categories.
Sensitivity analysis
We did not perform any of the planned sensitivity analyses since
none of the studies were at low risk of bias, standard deviation was
not imputed for any of the outcomes, there were no cluster RCTs,
and we either included studies with only two arms, or included
the data from only two arms.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer
Patient or population: pat ients with oesophageal cancer
Settings: upper gastrointest inal surgery unit
Intervention: laparoscopic transhiatal oesophagectomy
Control: open transhiatal oesophagectomy
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Assumed risk Corresponding risk
Open transhiatal
oesophagectomy
Laparoscopic transhiatal
oesophagectomy
Short- term recurrence
(within 6 months)
1 per 1000 1 per 1000
(0 to 18)
RR 0.88
(0.04 to 18.47)
20
(1 study)
⊕©©©
very low1,2,3
Long- term recurrence
Follow-up: 10 months
241 per 1000 241 per 1000
(207 to 278)
HR 1
(0.84 to 1.18)
173
(2 studies)
⊕©©©
very low1,3
Adverse events (propor-
tion)
623 per 1000 399 per 1000
(299 to 536)
RR 0.64
(0.48 to 0.86)
213
(3 studies)
⊕©©©
very low1,3
Blood transfusion (propor-
tion)
162 per 1000 13 per 1000
(0 to 219)
RR 0.08
(0 to 1.35)
73
(1 study)
⊕©©©
very low1,2,3
Blood transfusion (quan-
tity)
The median blood trans-
fused was 2.5 units
The median blood trans-
fused was 2.5units less
(conf idence intervals - not
available; statistical signif-
icance - not known)
93
(1 study)
⊕©©©
very low1,3
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Length of hospital stay The median hospital stay
rangedbetween 11 and 16
days
The median hospital stay
was 3 days less (conf idence
intervals - not available; sta-
tistically significant)
266
(3 studies)
⊕©©©
very low1,3
Positive resection margins 243 per 1000 158 per 1000
(90 to 272)
RR 0.65
(0.37 to 1.12)
213
(3 studies)
⊕©©©
very low1,2,3
Number of harvested lymph
nodes
The median number of
lymph nodes harvested
ranged between 11 and 36
The median number of
lymph nodes was 12 fewer
to 3 more (conf idence inter-
vals - not available; not sta-
tistically significant or sta-
tistical significance - not
known)
326
(5 studies)
⊕©©©
very low1,3,4
None of the studies reported time- to- return to normal activity (return to pre-operative mobility without additional caregiver support), or time- to- return to work.
* The basis for the assumed risk is the mean control group proport ion except for short-term recurrence where a control group proport ion of 0.1% was used since there was no
recurrence in the control group. The corresponding risk (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the
intervent ion (and its 95% CI).
CI: Conf idence interval; RR: Risk rat io; HR: Hazard rat io.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Risk of bias was unclear or high in the study/ studies.
2 The conf idence intervals were wide (overlapped clinically signif icant ef fects and no ef fect).
3 The sample size was small.
4 The results were inconsistent across studies.
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D I S C U S S I O N
Summary of main results
In this systematic review, we compared the benefits and harms of
laparoscopic versus open transhiatal oesophagectomy. We found
no randomised controlled trials on this topic. We included six ob-
servational studies that compared laparoscopic versus open tran-
shiatal oesophagectomy; five studies (326 patients: 151 patients
underwent laparoscopic and 175 patients underwent open tran-
shiatal oesophagectomy) provided information for one or more
outcomes. There were no statistically significant differences be-
tween laparoscopic and open transhiatal oesophagectomy in terms
of short-termmortality, long-termmortality, anastomotic stenosis,
short-term recurrence, long-term recurrence, proportion of people
who required blood transfusion, proportion of people with posi-
tive resection margins, or the number of lymph nodes harvested
during surgery. The proportion of patients with serious adverse
events, all adverse events, and the median length of hospital stay
were significantly less in the laparoscopic group than open oe-
sophagectomy group. There was lack of clarity as to whether the
median difference in the quantity of blood transfused was statisti-
cally significant, in favour of laparoscopic oesophagectomy. None
of the studies reported post-operative dysphagia, health-related
quality of life, time-to-return to normal activity (return to pre-
operative mobility without additional caregiver support), or time-
to-return to work.
In other surgeries, laparoscopic surgery has been shown to be ad-
vantageous over open surgery, with fewer complications, shorter
hospital stays, or both (Bijen 2009; Keus 2006; Reza 2006; Walsh
2009). So, the reduction of adverse events and length of hospital
stays is not an isolated phenomenon in transhiatal oesophagec-
tomy, and is biologically plausible. Since direct visualisation of
the lower mediastinum is possible in laparoscopic rather than in
open transhiatal oesophagectomy where the mediastinal dissec-
tion is blind, lower morbidity with laparoscopic oesophagectomy
is plausible (Yamamoto 2013).
Adverse events, serious adverse events, and length of hospital stays
are important patient-oriented outcomes. There was no statisti-
cally significant difference in the long-termmortality or long-term
recurrence between the two groups. The confidence intervals were
relatively narrow, and in the absence of bias, one may be able to
conclude that there was no difference in the long-term mortality
or long-term recurrence between the groups. This could suggest
that laparoscopic transhiatal oesophagectomywas superior to open
transhiatal oesophagectomy in the short-term, without affecting
the long-term outcomes. However, our major concerns about the
findings are the risks of selection bias, which are discussed further
in the Quality of the evidence section, and the relatively small
sample sizes, which make the findings unreliable due to both sys-
tematic and random errors.
Overall completeness and applicability of
evidence
The studies in this review included both adenocarcinoma and
squamous cell carcinoma and different stages (I to III) of oe-
sophageal cancer. Hence, the findings of this review are applicable
to all oesophageal cancers that are amenable for potentially curative
surgery. Two studies clearly mentioned that they included mainly
ASA I to III patients (Maas 2012; Valenti 2008). The remaining
studies did not state the ASA-status of patients. In any case, all
of the studies only included patients who could withstand major
surgery. Hence, the findings of this review are only applicable to
this population.
Quality of the evidence
The overall quality of evidence was very low. The major reasons
for this were that the studies were observational studies; conse-
quently, the risk of confounding bias was unclear. Studies did not
report baseline differences of all the confounding factors and the
sample sizes were not sufficient to identify differences in the con-
founding factors. Even if the sample sizes were large and all the
confounding factors were reported, one cannot rule out the prob-
lem of residual confounding. It is not clear whether this would
have introduced bias in the results. In two studies, the decision to
perform laparoscopic or open oesophagectomy was based on the
surgeon’s preference (Saha 2009; Valenti 2008). It is quite possi-
ble that patients with less extensive cancer were operated on la-
paroscopically while those with more extensive cancer had open
surgery. In Cash 2014, the authors performed laparoscopic oe-
sophagectomy after a certain date and compared the results of la-
paroscopic oesophagectomy with those of open oesophagectomy
performed prior to this date. Despite reporting on a consecutive
cohort of patients who had undergone open oesophagectomy, the
tumour size was smaller in patients who had undergone laparo-
scopic surgery, and this group also received neo-adjuvant therapy
more often (Cash 2014). This practice either reflects the anxiety of
the surgeon about the curative nature of the laparoscopic surgery
or an improvement in practice over time (neo-adjuvant chemo-
therapy improves survival in patients who undergo oesophagec-
tomy (Sjoquist 2011)). The selection process of patients for oe-
sophagectomy may also have improved over time.
Unless randomised controlled trials are conducted, which ensure
that the same type of participants have the opportunity to receive
either laparoscopic or open transhiatal oesophagectomy, one can-
not draw any reliable conclusions on the safety and effectiveness of
laparoscopic versus open transhiatal oesophagectomy, because of
residual confounding, i.e. we cannot infer causal association based
on the current studies. In terms of other types of bias, many of the
outcomes were subjective and the retrospective nature of most of
the studies means that blinding of outcome assessors is extremely
unlikely, which may also introduce bias. The complications were
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not reported adequately in most studies, which introduces selec-
tive outcome reporting bias.
Small sample sizes resulted inwide confidence intervals formany of
the outcomes, andwere another factor that decreased the quality of
evidence. Future studies should be adequately powered tomeasure
differences in clinically important outcomes.
On a positive note, we found no heterogeneity in the estimates of
effect between the studies, despite the differences in study designs.
Potential biases in the review process
We had planned to only include randomised controlled trials in
this review. However, in the absence of any randomised controlled
trials, we have reported the best available evidence on the topic.
We removed the ’randomised controlled trial’ term to ensure that
observational studies were not removed by the electronic filters.
Three authors independently selected studies, without any lan-
guage restrictions, and extracted data, which decreased the poten-
tial errors in study selection and data extraction. However, this is a
systematic review of non-randomised studies. There is no manda-
tory registration requirement, so studies that show poorer results
for laparoscopic oesophagectomy than open oesophagectomy may
not have been submitted to the journals since laparoscopic oe-
sophagectomy is a new procedure compared to the established
treatment of open oesophagectomy. So, we cannot rule out pub-
lication bias.
Agreements and disagreements with other
studies or reviews
This is the first systematic review on the topic. Three study au-
thors concluded that laparoscopic transhiatal oesophagectomywas
safe, reduced hospital stay, and was the preferable option (Badessi
2003; Cash 2014; Ecker 2015). Four study authors suggested that
laparoscopic transhiatal oesophagectomy offered equivalent on-
cological outcomes (Cash 2014; Ecker 2015; Saha 2009; Valenti
2008). One study author suggested that a randomised controlled
trial was necessary to assess the role of laparoscopic transhiatal oe-
sophagectomy in treating oesophageal cancers (Maas 2012). We
agree with the last statement that a randomised controlled trial is
necessary to assess the role of laparoscopic surgery in people under-
going transhiatal oesophagectomy. However, since transthoracic
oesophagectomy is believed to offer a long-term survival advan-
tage over transhiatal oesophagectomy, despite higher post-opera-
tive morbidity and mortality, and there is a lack of evidence of a
difference in the five-year survival compared with transhiatal oe-
sophagectomy, randomised controlled trials should examine min-
imally invasive oesophagectomy (thoracoscopic Ivor-Lewis pro-
cedure or combined thoracoscopic and laparoscopic McKneown
procedure), and other forms of oesophagectomy to identify the
optimal method of oesophagectomy (Boshier 2011; Colvin 2011;
Omloo 2007).
We calculated the hazard ratio for long-term mortality and long-
term recurrence using methods suggested in Parmar 1998. This
assumes constant proportional hazards. From the Kaplan-Meier
curves in the studies, the proportional hazards appeared constant
for long-term mortality. We were unable to test this assumption
for long-term recurrence since the Kaplan-Meier curves were not
available.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There are currently no randomised controlled trials comparing
laparoscopic with open transhiatal oesophagectomy for patients
with oesophageal cancers. In observational studies, laparoscopic
transhiatal oesophagectomy is associated with fewer complications
and shorter hospital stays than open transhiatal oesophagectomy.
However, this association is unlikely to be causal. There is currently
no information to determine a causal association in the differences
between laparoscopic versus open transhiatal oesophagectomy.
Implications for research
Future studies should try and address as many issues mentioned
below as possible. The rationale for the study design is also men-
tioned alongside.
Study design: Randomised controlled trial (only a randomised
controlled trial can establish a causal association in this situation).
Participants: People with potentially resectable oesophageal cancer
(Stages I to III adenocarcinoma or squamous cell carcinoma of the
oesophagus) and fit to undergo major surgery.
Intervention: Laparoscopic transhiatal oesophagectomy.
Control: Minimally invasive oesophagectomy (thoracoscopic Ivor
Lewis procedure or combined thoracoscopic and laparoscopic
McKeown’s procedure), or open oesophagectomy.
Outcomes: Important patient-oriented measures, such as short-
term and long-term mortality (at least two to three years), health-
related quality of life, complications and the sequelae of the com-
plications, measures of earlier post-operative recovery, such as
length of hospital stay, time-to-return to normal activity, and time-
to-return to work (in those who are employed), and recurrence of
cancer. In addition, resource use can be collected if the purpose
was cost-effectiveness and clinical effectiveness.
Five-year follow-up has been suggested, since oesophageal cancers
diagnosed early may have long-survival periods.
Other aspects of study design:
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• Observer-blinded randomised controlled trial: to control
for selection and detection bias.
• Identical care apart from laparoscopic versus open
oesophagectomy: to control for performance bias.
• Include all participants in the analysis and perform an
intention-to-treat analysis: to control for attrition bias.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Badessi 2003
Methods Not clear whether this is a cohort study or case-control study
Participants Country: Italy
Number eligible: 8
Number excluded: not stated
Number analysed: 8
Average age: not stated
Females: 3 (37.5%)
Stage I: not stated
Stage II: not stated
Stage III: not stated
Stage IV: not stated
Squamous cell carcinoma: not stated
Adenocarcinoma: not stated
Study design: retrospective study (no further details)
Total follow-up in months: not stated
ASA: not stated
Location: not stated
Inclusion criteria
Patients undergoing transhiatal oesophagectomy
Interventions Group 1: laparoscopic transhiatal oesophagectomy (N = 5).
Further details: number of ports - not stated; minilaparotomy incision size - not stated;
drain use - not stated.
Group 2: open transhiatal oesophagectomy (N = 3).
Further details: incision size - not stated; drain use - not stated
Outcomes None of the outcomes of interest were reported (adverse events and length of hospital
stay were reported but not in sufficient details to allow inclusion for meta-analysis)
Notes Proportion of people with cancer: 100%
Conversion: not stated
Risk of bias
Bias Authors’ judgement Support for judgement
Bias due to confounding Unclear risk No information
Comment: There was no mention about
baseline differences.
Bias due to selection of participants to in-
tervention and control
Unclear risk No information
Comment: Method of selection of partici-
pants to intervention and control was not
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Badessi 2003 (Continued)
reported
Bias due to differences in co-interventions
which were different between the groups
Unclear risk No information
Comment: It was not clear there were other
differences in care of the patient apart from
the intervention and control
Bias in the measurement of outcomes Unclear risk No information
Comment: Information on observer blind-
ing was not available.
Bias due to missing data Unclear risk No information
Comment: This information was not avail-
able.
Bias in selection of the reported findings High risk Critical risk of bias
Comment: None of the outcomes of inter-
est were reported.
Cash 2014
Methods Study design: retrospective cohort study
Participants Country: USA.
Number eligible: 93.
Number excluded: not stated.
Number analysed: 93.
Average age: 74 years.
Females: 20 (21.5%).
Stage I: 37(39.8%).
Stage II: 22 (23.7%).
Stage III: 34 (36.6%).
Stage IV: not stated
Squamous cell carcinoma: not stated
Adenocarcinoma: not stated
Study design: Retrospective cohort study with historical control
Total follow-up in months: median: 26 months for laparoscopic oesophagectomy group
and 64 months for open oesophagectomy group (survival at 24 months was used for
calculation of proportion survived)
ASA: not stated
Location: not stated
Inclusion criteria
Patients undergoing transhiatal oesophagectomy for oesophageal cancer
Exclusion criteria
People who had undergone major abdominal surgery.
Interventions Group 1: laparoscopic transhiatal oesophagectomy (N = 33).
Further details: number of ports - not stated; minilaparotomy - incision size not stated;
drain use - not stated.
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Cash 2014 (Continued)
Group 2: open transhiatal oesophagectomy (N = 60).
Further details: incision size - not stated; drain use - not stated
Outcomes The outcomes reported were short-term and long-term mortality, morbidity, long-term
recurrence, length of hospital stay, and number of lymph nodes harvested
Notes Proportion of people with cancer: 100%
Conversion: 2/33 (6.1%)
Risk of bias
Bias Authors’ judgement Support for judgement
Bias due to confounding High risk Critical risk of bias
Comment: The tumour size was smaller in
the laparoscopic group but more patients
had neo-adjuvant therapy in the laparoscopic
group
Bias due to selection of participants to in-
tervention and control
Low risk Moderate
Comment: This was a consecutive se-
ries of laparoscopic oesophagectomies where
the surgeon performed all transhiatal oe-
sophagectomies laparoscopically other than
for those who had undergone major abdom-
inal surgery after July 2008
Bias due to differences in co-interventions
which were different between the groups
Unclear risk No information
Comment: A historical control was used. It
was not clear there were other differences in
care of the patient apart from the interven-
tion and control
Bias in the measurement of outcomes Unclear risk No information
Comment: Information on observer blind-
ing was not available.
Bias due to missing data Unclear risk No information
Comment: This information was not avail-
able.
Bias in selection of the reported findings Low risk Low risk of bias
Comment: Mortality and morbidity were re-
ported.
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Ecker 2015
Methods Study design: retrospective cohort study
Participants Country: USA.
Number eligible: 73.
Post-randomisation drop-outs: 0 (0%).
Number analysed: 73.
Average age: 64 years.
Females: 16 (21.9%).
Stage I: 13(17.8%).
Stage II: 19 (26%).
Stage III: 31 (42.5%).
Stage IV: not stated
Squamous cell carcinoma: 4 (5.5%).
Adenocarcinoma: 68 (93.2%).
Study design: Retrospective cohort study with contemporary controls
Total follow-up in months: median:10 months
ASA: not stated
Location: not stated
Inclusion criteria
Patients undergoing transhiatal oesophagectomy
Interventions Group 1: laparoscopic transhiatal oesophagectomy (N = 36).
Further details: number of ports - not stated; minilaparotomy incision size - not stated;
drain use - not stated.
Group 2: open transhiatal oesophagectomy (N = 37).
Further details: incision size - not stated; drain use - not stated
Outcomes The outcomes reported were short-term and long-term mortality, oesophageal stenosis,
short-term recurrence, blood transfusion, length of hospital stay, positive resection mar-
gin, and number of lymph nodes harvested
Notes Proportion of people with cancer: 96% to 99% (error in the number of patients with
different aetiologies)
Conversion: 4/36 (11.1%)
Risk of bias
Bias Authors’ judgement Support for judgement
Bias due to confounding Unclear risk No information
Comment: There was no evidence of base-
line differences between the groups. How-
ever, the sample size was not sufficient to
identify baseline differences. In addition, not
all confounding factors were listed in the
baseline differences table (for example, no in-
formation was presented on the differences
in the size of the tumours)
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Ecker 2015 (Continued)
Bias due to selection of participants to in-
tervention and control
Unclear risk No information
Comment: Method of selection of partici-
pants to intervention and control was not re-
ported
Bias due to differences in co-interventions
which were different between the groups
Unclear risk No information
Comment: It was not clear there were other
differences in care of the patient apart from
the intervention and control
Bias in the measurement of outcomes Unclear risk No information
Comment: Information on observer blind-
ing was not available.
Bias due to missing data Low risk Low risk of bias
Comment: All patients were included in the
analysis.
Bias in selection of the reported findings High risk Serious risk of bias
Comment: Morbidity was not reported.
Maas 2012
Methods Study design: retrospective cohort study
Participants Country: Netherlands.
Number eligible: 100.
Post-randomisation drop-outs: 0 (0%).
Number analysed: 100.
Average age: 64 years.
Females: 26 (26%).
Stage I: 7(7%).
Stage II: 31 (31%).
Stage III: 62 (62%).
Stage IV: 0(0%).
Squamous cell carcinoma: 28 (28%).
Adenocarcinoma: 69 (69%).
Study design: Retrospective cohort study with historical control
Total follow-up in months: not stated
ASA: ASA I or II: 38 versus 36; ASA III or IV: 12 versus 14
Location: lower third
Inclusion criteria
Patients undergoing transhiatal oesophagectomy for distal oesophageal cancer
Exclusion criteria
Patients with colon interposition
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Maas 2012 (Continued)
Interventions Group 1: laparoscopic transhiatal oesophagectomy (N = 50).
Further details: number of ports - 5; minilaparotomy - 7 cm periumbilical incision);
drain use - not stated.
Group 2: open transhiatal oesophagectomy (N = 50).
Further details: incision size - not stated; drain use - not stated
Outcomes The outcomes reported were short-term and long-term mortality, morbidity, long-term
recurrence, length of hospital stay, positive resectionmargin, and number of lymph nodes
harvested
Notes Proportion of people with cancer: 100%
Conversion: 9/50 (18%)
Risk of bias
Bias Authors’ judgement Support for judgement
Bias due to confounding Unclear risk No information
Comment: There was no evidence of base-
line differences between the groups. How-
ever, the sample size was not sufficient to
identify baseline differences. In addition, not
all confounding factors were listed in the
baseline differences table (for example, no in-
formation was presented on the differences
in the size of the tumours)
Bias due to selection of participants to in-
tervention and control
Unclear risk Moderate risk of bias
Comment: This was a consecutive se-
ries of laparoscopic oesophagectomies where
the surgeon performed all transhiatal oe-
sophagectomies laparoscopically after Jan-
uary 2001
Bias due to differences in co-interventions
which were different between the groups
Unclear risk No information
Comment: A historical control was used. It
was not clear there were other differences in
care of the patient apart from the interven-
tion and control
Bias in the measurement of outcomes High risk Critical risk of bias
Comment: The assessment of the patients
was not done blinded (author replies)
Bias due to missing data Low risk Low risk of bias
Comment: All patients were included in the
analysis.
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Maas 2012 (Continued)
Bias in selection of the reported findings Low risk Low risk of bias
Comment: Mortality and morbidity were re-
ported adequately.
Saha 2009
Methods Study design: retrospective cohort study
Participants Country: UK.
Number eligible: 20.
Number excluded: 0 (0%).
Number analysed: 20.
Average age: 65 years.
Females: 4 (20%).
Stage I: 20(100%).
Stage II: 0 (0%).
Stage III: 0 (0%).
Stage IV: 0(0%).
Squamous cell carcinoma: 0 (0%).
Adenocarcinoma: 20 (100%).
Study design: Retrospective cohort study with contemporary controls
Total follow-up in months: median: 44 months
ASA: not stated
Location: lower third
Inclusion criteria
Patients undergoing oesophagectomy for T1 oesophageal adenocarcinoma
Interventions Group 1: laparoscopic transhiatal oesophagectomy (N = 16).
Further details: Number of ports - 5; minilaparotomy incision size - not stated; drain
use - not stated.
Group 2: open transhiatal oesophagectomy (N = 4).
Further details: incision size - not stated; drain use - not stated
Outcomes The outcomes reported were short-term mortality, long-term recurrence, and number
of lymph nodes harvested
Notes Proportion of people with cancer: 100%
Conversion: not stated
Risk of bias
Bias Authors’ judgement Support for judgement
Bias due to confounding Unclear risk No information
Comment: There was no evidence of base-
line differences between the groups. How-
ever, the sample size was not sufficient to
identify baseline differences. In addition, not
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Saha 2009 (Continued)
all confounding factors were listed in the
baseline differences table (for example, no in-
formation was presented on the differences
in the size of the tumours)
Bias due to selection of participants to in-
tervention and control
Unclear risk No information
Comment: Patients were selected for laparo-
scopic transhiatal or open resection at the dis-
cretion of the surgeon
Bias due to differences in co-interventions
which were different between the groups
Unclear risk No information
Comment: It was not clear there were other
differences in care of the patient apart from
the intervention and control
Bias in the measurement of outcomes High risk Critical risk of bias
Quote: “Outcome assessors were not blinded
(author replies)”
Bias due to missing data Low risk Low risk of bias
Comment: All patients were included in the
analysis.
Bias in selection of the reported findings High risk Serious risk of bias
Comment: Morbidity was not reported.
Valenti 2008
Methods Study design: prospective cohort study
Participants Country: UK.
Number eligible: 40.
Number excluded: 0 (0%).
Number analysed: 40.
Average age: 67 years.
Females: 8 (20%).
Stage I: not stated
Stage II: not stated
Stage III: not stated
Stage IV: not stated
Squamous cell carcinoma: 9 (22.5%).
Adenocarcinoma: 28 (70%).
Study design: Prospective cohort study with contemporary controls
Total follow-up in months: not stated
ASA: ASA I or II: 12 versus 17; ASA III or IV: 4 versus 7
Location: lower third
Inclusion criteria
Patients undergoing transhiatal oesophagectomy for oesophageal cancer
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Valenti 2008 (Continued)
Interventions Group 1: laparoscopic transhiatal oesophagectomy (N = 16).
Further details: number of ports - 5; minilaparotomy - 7 cm incision; drain use - not
stated.
Group 2: open transhiatal oesophagectomy (N = 24).
Further details: incision size - not stated; drain used- not stated
Outcomes The outcomes reported were short-termmortality and number of lymphnodes harvested
Notes Proportion of people with cancer: 93% (remaining patients had high grade dysplasia)
Conversion: 0/16 (0%)
Risk of bias
Bias Authors’ judgement Support for judgement
Bias due to confounding Unclear risk No information
Comment: There was no evidence of baseline
differences between the groups. However, the
sample size was not sufficient to identify base-
line differences. In addition, not all confound-
ing factors were listed in the baseline differ-
ences table (for example, no information was
presented on the differences in the stage of the
tumours)
Bias due to selection of participants to in-
tervention and control
Unclear risk No information
Comment: Method of selection of partici-
pants to intervention and control was based
on surgeon’s preference
Bias due to differences in co-interventions
which were different between the groups
Unclear risk No information
Comment: It was not clear there were other
differences in care of the patient apart from
the intervention and control
Bias in the measurement of outcomes High risk High risk of bias
Quote: “No blinded assessors (author replies)
”.
Bias due to missing data Low risk Low risk of bias
Quote: “No patients excluded from analysis
(author replies)”
Bias in selection of the reported findings High risk Serious risk of bias
Comment: Morbidity was not reported.
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bernabe 2005 Transhiatal oesophagectomy was performed for less than 90% of oesophageal cancers and separate data were
not available for people with pancreatic cancers
Blazeby 2011 Not transhiatal oesophagectomy
Bresadola 2006 No separate data for transhiatal oesophagectomy
Burdall 2015 Not transhiatal oesophagectomy
Csendes 2013 Not transhiatal oesophagectomy
Cuesta 2012 Editorial
Dolan 2013 Not transhiatal oesophagectomy
Fabian 2008 No separate data for transhiatal oesophagectomy
Ferreira 2004 Review
Harrison 2013 Unclear whether transhiatal oesophagectomies were included
Kang 2013 No separate data for transhiatal oesophagectomy
Lee 2013 Cost-effectiveness study with no primary research data
Mamidanna 2012 No separate data for transhiatal oesophagectomy
Mao 2012 No separate data for transhiatal oesophagectomy
Mariette 2012 Letter to editor
Messenger 2015 No separate data for transhiatal oesophagectomy
Parameswaran 2013 Not transhiatal oesophagectomy
Perry 2009 Transhiatal oesophagectomy was performed for less than 90% of oesophageal cancers and separate data were
not available for people with pancreatic cancers
Rice 2012 Editorial
Safranek 2010 Not transhiatal oesophagectomy
Scheepers 2008 No control group
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(Continued)
Schoppmann 2010 Not transhiatal oesophagectomy
Ujiki 2013 Comment on excluded study (Perry 2009)
Yamasaki 2011 Not transhiatal oesophagectomy
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D A T A A N D A N A L Y S E S
Comparison 1. Laparoscopic versus open transhiatal oesophagectomy
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Short-term mortality 5 326 Risk Ratio (M-H, Fixed, 95% CI) 0.44 [0.05, 4.09]
2 Long-term mortality 2 193 Hazard Ratio (Fixed, 95% CI) 0.97 [0.81, 1.16]
3 Serious adverse events
(proportion)
3 213 Risk Ratio (M-H, Fixed, 95% CI) 0.49 [0.24, 0.99]
4 Anastomotic stenosis 1 73 Risk Ratio (M-H, Fixed, 95% CI) 1.37 [0.33, 5.70]
5 Short-term recurrence (within 6
months)
1 20 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.04, 18.47]
6 Long-term recurrence 2 173 Hazard Ratio (Fixed, 95% CI) 1.00 [0.84, 1.18]
7 Adverse events (proportion) 3 213 Risk Ratio (M-H, Fixed, 95% CI) 0.64 [0.48, 0.86]
8 Blood transfusion (proportion) 1 73 Risk Ratio (M-H, Fixed, 95% CI) 0.08 [0.00, 1.35]
9 Blood transfusion (quantity) Other data No numeric data
10 Length of hospital stay Other data No numeric data
11 Positive resection margins 3 213 Risk Ratio (M-H, Fixed, 95% CI) 0.65 [0.37, 1.12]
12 Number of lymph nodes
harvested
Other data No numeric data
Comparison 2. Laparoscopic versus open transhiatal oesophagectomy (Subgroup analyses)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Serious adverse events
(proportion) (stage I
adenocarcinoma)
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Short-term mortality
(lower-third cancer)
3 160 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 7.99]
3 Long-term mortality (lower
third cancer)
1 Hazard Ratio (Fixed, 95% CI) Totals not selected
4 Serious adverse events
(proportion) (lower third
cancer)
2 120 Risk Ratio (M-H, Fixed, 95% CI) 0.45 [0.17, 1.22]
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Analysis 1.1. Comparison 1 Laparoscopic versus open transhiatal oesophagectomy, Outcome 1 Short-term
mortality.
Review: Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer
Comparison: 1 Laparoscopic versus open transhiatal oesophagectomy
Outcome: 1 Short-term mortality
Study or subgroup Laparoscopic group Open group Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cash 2014 0/33 1/60 41.7 % 0.60 [ 0.03, 14.28 ]
Ecker 2015 0/36 0/37 Not estimable
Maas 2012 0/50 1/50 58.3 % 0.33 [ 0.01, 7.99 ]
Saha 2009 0/16 0/4 Not estimable
Valenti 2008 0/16 0/24 Not estimable
Total (95% CI) 151 175 100.0 % 0.44 [ 0.05, 4.09 ]
Total events: 0 (Laparoscopic group), 2 (Open group)
Heterogeneity: Chi2 = 0.07, df = 1 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 0.72 (P = 0.47)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours laparoscopic Favours open
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Analysis 1.2. Comparison 1 Laparoscopic versus open transhiatal oesophagectomy, Outcome 2 Long-term
mortality.
Review: Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer
Comparison: 1 Laparoscopic versus open transhiatal oesophagectomy
Outcome: 2 Long-term mortality
Study or subgroup Laparoscopic group Open group log [Hazard Ratio] Hazard Ratio Weight Hazard Ratio
N N (SE) IV,Fixed,95% CI IV,Fixed,95% CI
Cash 2014 33 60 -0.15415 (0.204707) 20.8 % 0.86 [ 0.57, 1.28 ]
Maas 2012 50 50 -0.00128 (0.104893) 79.2 % 1.00 [ 0.81, 1.23 ]
Total (95% CI) 83 110 100.0 % 0.97 [ 0.81, 1.16 ]
Heterogeneity: Chi2 = 0.44, df = 1 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 0.35 (P = 0.72)
Test for subgroup differences: Not applicable
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Analysis 1.3. Comparison 1 Laparoscopic versus open transhiatal oesophagectomy, Outcome 3 Serious
adverse events (proportion).
Review: Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer
Comparison: 1 Laparoscopic versus open transhiatal oesophagectomy
Outcome: 3 Serious adverse events (proportion)
Study or subgroup Laparoscopic group Open group Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cash 2014 4/33 14/60 48.4 % 0.52 [ 0.19, 1.45 ]
Maas 2012 4/50 9/50 43.8 % 0.44 [ 0.15, 1.35 ]
Saha 2009 2/16 1/4 7.8 % 0.50 [ 0.06, 4.23 ]
Total (95% CI) 99 114 100.0 % 0.49 [ 0.24, 0.99 ]
Total events: 10 (Laparoscopic group), 24 (Open group)
Heterogeneity: Chi2 = 0.04, df = 2 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 1.99 (P = 0.047)
Test for subgroup differences: Not applicable
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Analysis 1.4. Comparison 1 Laparoscopic versus open transhiatal oesophagectomy, Outcome 4
Anastomotic stenosis.
Review: Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer
Comparison: 1 Laparoscopic versus open transhiatal oesophagectomy
Outcome: 4 Anastomotic stenosis
Study or subgroup Laparoscopic group Open group Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ecker 2015 4/36 3/37 100.0 % 1.37 [ 0.33, 5.70 ]
Total (95% CI) 36 37 100.0 % 1.37 [ 0.33, 5.70 ]
Total events: 4 (Laparoscopic group), 3 (Open group)
Heterogeneity: not applicable
Test for overall effect: Z = 0.43 (P = 0.66)
Test for subgroup differences: Not applicable
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Analysis 1.5. Comparison 1 Laparoscopic versus open transhiatal oesophagectomy, Outcome 5 Short-term
recurrence (within 6 months).
Review: Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer
Comparison: 1 Laparoscopic versus open transhiatal oesophagectomy
Outcome: 5 Short-term recurrence (within 6 months)
Study or subgroup Laparoscopic group Open group Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Saha 2009 1/16 0/4 100.0 % 0.88 [ 0.04, 18.47 ]
Total (95% CI) 16 4 100.0 % 0.88 [ 0.04, 18.47 ]
Total events: 1 (Laparoscopic group), 0 (Open group)
Heterogeneity: not applicable
Test for overall effect: Z = 0.08 (P = 0.94)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 Laparoscopic versus open transhiatal oesophagectomy, Outcome 6 Long-term
recurrence.
Review: Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer
Comparison: 1 Laparoscopic versus open transhiatal oesophagectomy
Outcome: 6 Long-term recurrence
Study or subgroup Laparoscopic group Open group log [Hazard Ratio] Hazard Ratio Weight Hazard Ratio
N N (SE) IV,Fixed,95% CI IV,Fixed,95% CI
Ecker 2015 36 37 0.182322 (0.267706) 10.4 % 1.20 [ 0.71, 2.03 ]
Maas 2012 50 50 -0.02106 (0.091371) 89.6 % 0.98 [ 0.82, 1.17 ]
Total (95% CI) 86 87 100.0 % 1.00 [ 0.84, 1.18 ]
Heterogeneity: Chi2 = 0.52, df = 1 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 0.00 (P = 1.0)
Test for subgroup differences: Not applicable
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Analysis 1.7. Comparison 1 Laparoscopic versus open transhiatal oesophagectomy, Outcome 7 Adverse
events (proportion).
Review: Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer
Comparison: 1 Laparoscopic versus open transhiatal oesophagectomy
Outcome: 7 Adverse events (proportion)
Study or subgroup Laparoscopic group Open group Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cash 2014 13/33 37/60 43.1 % 0.64 [ 0.40, 1.02 ]
Maas 2012 21/50 33/50 54.2 % 0.64 [ 0.43, 0.93 ]
Saha 2009 3/16 1/4 2.6 % 0.75 [ 0.10, 5.43 ]
Total (95% CI) 99 114 100.0 % 0.64 [ 0.48, 0.86 ]
Total events: 37 (Laparoscopic group), 71 (Open group)
Heterogeneity: Chi2 = 0.03, df = 2 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 2.97 (P = 0.0030)
Test for subgroup differences: Not applicable
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Analysis 1.8. Comparison 1 Laparoscopic versus open transhiatal oesophagectomy, Outcome 8 Blood
transfusion (proportion).
Review: Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer
Comparison: 1 Laparoscopic versus open transhiatal oesophagectomy
Outcome: 8 Blood transfusion (proportion)
Study or subgroup Laparoscopic group Open group Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ecker 2015 0/36 6/37 100.0 % 0.08 [ 0.00, 1.35 ]
Total (95% CI) 36 37 100.0 % 0.08 [ 0.00, 1.35 ]
Total events: 0 (Laparoscopic group), 6 (Open group)
Heterogeneity: not applicable
Test for overall effect: Z = 1.75 (P = 0.080)
Test for subgroup differences: Not applicable
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Analysis 1.9. Comparison 1 Laparoscopic versus open transhiatal oesophagectomy, Outcome 9 Blood
transfusion (quantity).
Blood transfusion (quantity)
Study Median number of units in laparo-
scopic oesophagectomy
Median number of units in open oe-
sophagectomy
Statistical significance
Cash 2014 0 2.5 The statistical significance was not
clear since the P value presented in this
study was for the comparison of three
groups (only two of which were eligi-
ble for this review)
Analysis 1.10. Comparison 1 Laparoscopic versus open transhiatal oesophagectomy, Outcome 10 Length of
hospital stay.
Length of hospital stay
Study Median hospital stay in
laparoscopic oesophagec-
tomy (days)
Me-
dian hospital stay in open
oesophagectomy (days)
Difference in median
(days)
Statistical significance
Badessi 2003 not reported not reported not reported Authors state that the post-
operative hospital stay was
shorter in the laparoscopic
group compared to the
open group without pro-
viding information on the
length of hospital stay or
statistical significance
Cash 2014 10 13 -3 Statistically significant
Ecker 2015 8 11 -3 Statistically significant
Maas 2012 13 16 -3 Statistically significant
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Analysis 1.11. Comparison 1 Laparoscopic versus open transhiatal oesophagectomy, Outcome 11 Positive
resection margins.
Review: Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer
Comparison: 1 Laparoscopic versus open transhiatal oesophagectomy
Outcome: 11 Positive resection margins
Study or subgroup Laparoscopic group Open group Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ecker 2015 1/36 3/37 12.0 % 0.34 [ 0.04, 3.14 ]
Maas 2012 9/50 13/50 52.5 % 0.69 [ 0.33, 1.47 ]
Valenti 2008 5/16 11/24 35.5 % 0.68 [ 0.29, 1.59 ]
Total (95% CI) 102 111 100.0 % 0.65 [ 0.37, 1.12 ]
Total events: 15 (Laparoscopic group), 27 (Open group)
Heterogeneity: Chi2 = 0.36, df = 2 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 1.56 (P = 0.12)
Test for subgroup differences: Not applicable
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Analysis 1.12. Comparison 1 Laparoscopic versus open transhiatal oesophagectomy, Outcome 12 Number
of lymph nodes harvested.
Number of lymph nodes harvested
Study Number of
harvested lymph nodes in
laparoscopic oesophagec-
tomy (measure)
Number of harvested
lymph nodes in open oe-
sophagectomy (measure)
Difference inmean orme-
dian
Statistical significance
Cash 2014 24 (median) 36 (median) -12 The statistical significance
was not clear since the
P value presented in this
study was for the compar-
ison of three groups (only
two of which were eligible
for this review)
Ecker 2015 14 (median) 16 (median) -2 Not statistically significant
Maas 2012 14 (median) 11 (median) 3 Not statistically significant
Saha 2009 15 (median) 16 (median) -1 Statistical significance was
not stated
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Number of lymph nodes harvested (Continued)
Valenti 2008 18 (mean) 19 (mean) -1 Not statistically significant
Analysis 2.1. Comparison 2 Laparoscopic versus open transhiatal oesophagectomy (Subgroup analyses),
Outcome 1 Serious adverse events (proportion) (stage I adenocarcinoma).
Review: Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer
Comparison: 2 Laparoscopic versus open transhiatal oesophagectomy (Subgroup analyses)
Outcome: 1 Serious adverse events (proportion) (stage I adenocarcinoma)
Study or subgroup Laparoscopic group Open group Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Saha 2009 2/16 1/4 0.50 [ 0.06, 4.23 ]
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Analysis 2.2. Comparison 2 Laparoscopic versus open transhiatal oesophagectomy (Subgroup analyses),
Outcome 2 Short-term mortality (lower-third cancer).
Review: Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer
Comparison: 2 Laparoscopic versus open transhiatal oesophagectomy (Subgroup analyses)
Outcome: 2 Short-term mortality (lower-third cancer)
Study or subgroup Laparoscopic group Open group Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Maas 2012 0/50 1/50 100.0 % 0.33 [ 0.01, 7.99 ]
Saha 2009 0/16 0/4 Not estimable
Valenti 2008 0/16 0/24 Not estimable
Total (95% CI) 82 78 100.0 % 0.33 [ 0.01, 7.99 ]
Total events: 0 (Laparoscopic group), 1 (Open group)
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
Test for subgroup differences: Not applicable
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Analysis 2.3. Comparison 2 Laparoscopic versus open transhiatal oesophagectomy (Subgroup analyses),
Outcome 3 Long-term mortality (lower third cancer).
Review: Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer
Comparison: 2 Laparoscopic versus open transhiatal oesophagectomy (Subgroup analyses)
Outcome: 3 Long-term mortality (lower third cancer)
Study or subgroup Laparoscopic group Open group log [Hazard Ratio] Hazard Ratio Hazard Ratio
N N (SE) IV,Fixed,95% CI IV,Fixed,95% CI
Maas 2012 50 50 -0.00128 (0.104893) 1.00 [ 0.81, 1.23 ]
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Analysis 2.4. Comparison 2 Laparoscopic versus open transhiatal oesophagectomy (Subgroup analyses),
Outcome 4 Serious adverse events (proportion) (lower third cancer).
Review: Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer
Comparison: 2 Laparoscopic versus open transhiatal oesophagectomy (Subgroup analyses)
Outcome: 4 Serious adverse events (proportion) (lower third cancer)
Study or subgroup Laparoscopic group Open group Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Maas 2012 4/50 9/50 84.9 % 0.44 [ 0.15, 1.35 ]
Saha 2009 2/16 1/4 15.1 % 0.50 [ 0.06, 4.23 ]
Total (95% CI) 66 54 100.0 % 0.45 [ 0.17, 1.22 ]
Total events: 6 (Laparoscopic group), 10 (Open group)
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 1.56 (P = 0.12)
Test for subgroup differences: Not applicable
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A P P E N D I C E S
Appendix 1. CENTRAL search strategy
#1 MeSH descriptor: [Esophagectomy] explode all trees
#2 (esophagectomyor esophagectomies or oesophagectomyor oesophagectomies or ((esophag* or oesophag*) and (resectionor resections
or removal or operation or operations)))
#3 #1 or #2
#4 MeSH descriptor: [Laparoscopy] explode all trees
#5 laparoscop*
#6 #4 or #5
#7 MeSH descriptor: [Esophageal Neoplasms] explode all trees
#8 (esophag* near/5 neoplas*)
#9 (oesophag* near/5 neoplas*)
#10 (esophag* near/5 cancer*)
#11 (oesophag* near/5 cancer*)
#12 (esophag* near/5 carcin*)
#13 (oesophag* near/5 carcin*)
#14 (esophag* near/5 tumo*)
#15 (oesophag* near/5 tumo*)
#16 (esophag* near/5 malig*)
#17 (oesophag* near/5 malig*)
#18 MeSH descriptor: [Esophagogastric Junction] explode all trees
#19 #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18
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#20 #3 and #6 and #19
Appendix 2. MEDLINE search strategy
1. exp Esophagectomy/
2. (esophagectomy or esophagectomies or oesophagectomy or oesophagectomies or ((esophag* or oesophag*) and (resection or resections
or removal or operation or operations))).mp.
3. 1 or 2
4. exp Laparoscopy/
5. laparoscop*.mp.
6. 4 or 5
7. exp esophageal neoplasms/
8. (esophag* adj5 neoplas*).tw.
9. (oesophag* adj5 neoplas*).tw.
10. (esophag* adj5 cancer*).tw.
11. (oesophag* adj5 cancer*).tw.
12. (esophag* adj5 carcin*).tw.
13. (oesophag* adj5 carcin*).tw.
14. (esophag* adj5 tumo*).tw.
15. (oesophag* adj5 tumo*).tw.
16. (esophag* adj5 malig*).tw.
17. (oesophag* adj5 malig*).tw.
18. exp esophagogastric junction/
19. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18
20. 3 and 6 and 19
Appendix 3. EMBASE search strategy
1. exp esophagus resection/
2. (esophagectomy or esophagectomies or oesophagectomy or oesophagectomies or ((esophag* or oesophag*) and (resection or resections
or removal or operation or operations))).mp.
3. 1 or 2
4. exp Laparoscopy/
5. laparoscop*.mp.
6. 4 or 5
7. exp esophagus tumor/
8. (esophag* adj5 neoplas*).tw.
9. (oesophag* adj5 neoplas*).tw.
10. (esophag* adj5 cancer*).tw.
11. (oesophag* adj5 cancer*).tw.
12. (esophag* adj5 carcin*).tw.
13. (oesophag* adj5 carcin*).tw.
14. (esophag* adj5 tumo*).tw.
15. (oesophag* adj5 tumo*).tw.
16. (esophag* adj5 malig*).tw.
17. (oesophag* adj5 malig*).tw.
18. exp lower esophagus sphincter/
19. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18
20. 3 and 6 and 19
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Appendix 4. Science Citation Index search strategy
#1 TS=(esophagectomy or esophagectomies or oesophagectomy or oesophagectomies or ((esophag* or oesophag*) and (resection or
resections or removal or operation or operations)))
#2 TS=(laparoscop*)
#3 TS=(esophag* near/5 neoplas*)
#4 TS=(oesophag* near/5 neoplas*)
#5 TS=(esophag* near/5 cancer*)
#6 TS=(oesophag* near/5 cancer*)
#7 TS=(esophag* near/5 carcin*)
#8 TS=(oesophag* near/5 carcin*)
#9 TS=(esophag* near/5 tumo*)
#10 TS=(oesophag* near/5 tumo*)
#11 TS=(esophag* near/5 malig*)
#12 TS=(oesophag* near/5 malig*)
#13 #12 OR #11 OR #10 OR #9 OR #8 OR #7 OR #6 OR #5 OR #4 OR #3
#14 #13 AND #2 AND #1
Appendix 5. ClinicalTrials.gov search strategy
Interventional Studies | esophageal cancer | laparoscopic | Phase 2, 3, 4
Appendix 6. WHO ICTRP search strategy
laparoscopic oesophagectomy or laparoscopic esophagectomy or laparoscopic oesophageal resection or laparoscopic esophageal resection
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
1. Since no randomised controlled trials were identified, we included non-randomised studies to provide the current best available
evidence. As a result, we made the following modifications to the protocol.
i) We did not use the filter for randomised controlled trials for the electronic searches of the databases.
ii) We used ’A Cochrane Risk Of Bias Assessment Tool: for Non-Randomized Studies of Interventions’ (ACROBAT-NRSI)
tool for assessment of risk of bias rather than the standard Cochrane risk of bias tool for randomised controlled trials.
2. We have noted under each outcome if outcome data were reported in an unusable way in one or more studies. In the protocol,
we stated that we will do this in the ’Characteristics of included studies’ table. However, it is unlikely the readers refer to the
Characteristics of included studies’ table while reading the results and it appeared more appropriate to provide this information under
each outcome.
49Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Adenocarcinoma [∗surgery]; Carcinoma, Squamous Cell [∗surgery]; Diaphragm; Esophageal Neoplasms [∗surgery]; Esophagectomy
[adverse effects; ∗methods]; Laparoscopy [∗methods]; Retrospective Studies
MeSH check words
Humans
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